Inventiva S.A.

IVA Nasdaq SEC CIK 1756594
Follow Inventiva Weekly email: filings, results, news

Financials

Reported figures only · latest: Q2 2025 EUR · IFRS
EPS, diluted -

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income8 fiscal years
  • Revenue
  • Net income
−€200M−€100M€0€100MFY17FY18FY19FY20FY21FY22FY23FY24
Show the numbers
YearRevenueNet income
FY24€9.2M−€184.2M
FY23€17.5M−€110.4M
FY22€12.2M−€54.3M
FY21€4.2M−€49.6M
FY20€372K−€33.6M
FY19€7M−€30.2M
FY18€3.2M−€33M
FY17--
MarginsShare of revenue
  • Operating margin
  • Net margin
−10000%−7500%−5000%−2500%0%FY17FY18FY19FY20FY21FY22FY23FY24
Show the numbers
YearOperating marginNet margin
FY24−1060.6%−2002.7%
FY23−587.7%−631.8%
FY22−468.9%−445.6%
FY21−1242.6%−1183.5%
FY20−7988.7%−9037.4%
FY19−433.2%−431.8%
FY18−1029.2%−1032.7%
FY17--
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Inventiva
  • Healthcare median
−10000%−7500%−5000%−2500%0%FY17FY18FY19FY20FY21FY22FY23FY24
Show the numbers
YearInventivaHealthcare median
FY24−2002.7%−86.4%
FY23−631.8%−123.6%
FY22−445.6%−138.2%
FY21−1183.5%−139.8%
FY20−9037.4%−143.7%
FY19−431.8%−143.3%
FY18−1032.7%−173.4%
FY17-−166.7%

News

No stories filed under Inventiva yet - coverage appears here as the news feed clusters it.